生物活性
Pazopanib (GW-786034)是VEGFR-1，VEGFR-2，VEGFR-3，PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂，可阻止肿瘤生长并抑制血管生成。
Targets
| Target | Value |
| VEGFR1 | IC50: 10nM |
| VEGFR2 | IC50: 30nM |
| VEGFR3 | IC50: 47nM |
| FGFR | IC50: 74nM |
| PDGFR | IC50: 84nM |
| c-Kit | IC50: 140nM |
| c-Fms | IC50: 146nM |
化学数据
| 目录号 | A11518 |
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 437.5 |
| Formula | C21H23N7O2S |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated.
In lyophilized form, the chemical is stable for36 months.
In solution, store at -20ºC and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
| CAS No. | 444731-52-6 |
| Synonyms | GW 786034, Votrient,GW786034 |
| SMILES | CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N |
溶解度
| In vitro | DMSO | Warmed: 84 mg/mL (191.98 mM) |
| Water | Insoluble |
| Ethanol | Insoluble |
*<1 mg/ml means slightly soluble or insoluble.
*Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
| 0.1 mM | 22.86 mL | 114.29 mL | 228.57 mL |
| 0.5 mM | 4.57 mL | 22.86 mL | 45.71 mL |
| 1 mM | 2.29 mL | 11.43 mL | 22.86 mL |
| 5 mM | 0.46 mL | 2.29 mL | 4.57 mL |
*The above data is based on the productmolecular weight 437.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
m.cnreagent.com